PBAC Public Summary Documents – April 2018
Page last updated: 9 November 2018
The following Public Summary Documents have been updated based on outcomes from the April 2018 meeting.
March 2018 PBAC meeting
- Filgrastim: Injection 120 micrograms in 0.2 mL single use pre filled syringe, Injection 300 micrograms in 0.5 mL single use pre filled syringe, Injection 480 micrograms in 0.5 mL single use pre filled syringe; Nivestim®
- Obinutuzumab: Solution for I.V. infusion, 1000 mg in 40 mL; GAZYVA®
November 2017 PBAC meeting
December 2017 PBAC meeting
- Fluticasone furoate with umeclidinium and vilanterol: Powder for oral inhalation in breath actuated device containing fluticasone furoate 100 micrograms with umeclidinium 62.5 micrograms (as bromide) and vilanterol 25 micrograms (as trifenatate) per dose; Trelegy® Ellipta®
